FHIR IG analytics| Package | uz.dhp.integrations |
| Resource Type | ConceptMap |
| Id | ConceptMap-dhis-observation-component-to-loinc.json |
| FHIR Version | R5 |
| Source | https://build.fhir.org/ig/uzinfocom-org/digital-health-integration/ConceptMap-dhis-observation-component-to-loinc.html |
| URL | https://terminology.dhp.uz/fhir/integrations/ConceptMap/dhis-observation-component-to-loinc |
| Version | 0.1.0 |
| Status | draft |
| Date | 2026-07-20T13:54:46+00:00 |
| Name | ObservationComponentToLoinc |
| Title | Tuberculosis Drug Susceptibility Components to LOINC |
| Description | Maps the local DHIS drug-susceptibility-test component codes to their LOINC [Susceptibility] code. Where the relationship is `equivalent` (plain drug-name agents), use the LOINC code directly in resources (see the DHIS Observation Component Code ValueSet); concentration-bearing agents are narrower and keep their local code. Non-drug component codes (interpretations, grading, identification flags) have no LOINC equivalent and are not listed. |
No resources found
| CodeSystem | ||
| kl.dk.fhir.children#2.1.0 | loinc.org | Logical Observation Identifiers, Names and Codes (LOINC) |
| uz.dhp.integrations#current | dhis-observation-component-code-cs | DHIS Observation Component Code CodeSystem |
Note: links and images are rebased to the (stated) source
English
Generated Narrative: ConceptMap dhis-observation-component-to-loinc
Mapping from (not specified) to All LOINC codes
Mapping from DHIS Observation Component Code CodeSystemversion: 0.1.0) to http://loinc.org (Logical Observation Identifier Names and Codes (LOINC))
| Source Code | Relationship | Target Code |
| tub004-0007 (Rifampitsin (1,0 mg/ml)) | is narrower than | 18974-6 (Rifampin [Susceptibility]) |
| tub004-0008 (Izoniazid (0,1 mg/ml)) | is narrower than | 18934-0 (Isoniazid [Susceptibility]) |
| tub004-0009 (Etambutol (5,0 mg/ml)) | is narrower than | 18921-7 (Ethambutol [Susceptibility]) |
| tub004-0010 (Pirazinamid (100 mg/ml)) | is narrower than | 18973-8 (Pyrazinamide [Susceptibility]) |
| tub004-0011 (Levofloksatsin (2,0 mg/ml)) | is narrower than | 20629-2 (Levofloxacin [Susceptibility]) |
| tub004-0012 (Moksifloksatsin (1,0 mg/ml)) | is narrower than | 31039-1 (Moxifloxacin [Susceptibility]) |
| tub004-0013 (Moksifloksatsin (0,25 mg/ml)) | is narrower than | 31039-1 (Moxifloxacin [Susceptibility]) |
| tub004-0014 (Gatifloksatsin (0,25 mg/ml)) | is narrower than | 31038-3 (Gatifloxacin [Susceptibility]) |
| tub004-0015 (Amikatsin (1,0 mg/ml)) | is narrower than | 18860-7 (Amikacin [Susceptibility]) |
| tub004-0016 (Protionamid (2,5 mg/ml)) | is narrower than | 100057-9 (Prothionamide [Susceptibility]) |
| tub004-0017 (Linezolid (1,0 mg/ml)) | is narrower than | 29258-1 (Linezolid [Susceptibility]) |
| tub004-0018 (Klofazimin (1,0 mg/ml)) | is narrower than | 23627-3 (Clofazimine [Susceptibility]) |
| tub004-0019 (Bedaquilin (1,0 mg/ml)) | is narrower than | 94274-8 (Bedaquiline [Susceptibility]) |
| tub004-0020 (Delamanid (0,06 mg/ml)) | is narrower than | 93851-4 (Delamanid [Susceptibility]) |
| tub004-0021 (Pretomanid (1,0 mg/ml)) | is narrower than | 93850-6 (Pretomanid [Susceptibility]) |
| tub004-0025 (Ethionamide-Prothionamide) | is related to | 18922-5 (Ethionamide [Susceptibility]) |
| tub004-0022 (Rifampcin) | is equivalent to | 18974-6 (Rifampin [Susceptibility]) |
| tub004-0028 (Levofloxacin) | is equivalent to | 20629-2 (Levofloxacin [Susceptibility]) |
| tub004-0029 (Amikacin) | is equivalent to | 18860-7 (Amikacin [Susceptibility]) |
| tub004-0030 (Kanamycin) | is equivalent to | 18935-7 (Kanamycin [Susceptibility]) |
Russian
Сгенерированный нарратив: ConceptMap dhis-observation-component-to-loinc
Сопоставление с (не указано) до All LOINC codes
Сопоставление с DHIS Observation Component Code CodeSystemверсия: 0.1.0) to http://loinc.org (Logical Observation Identifier Names and Codes (LOINC))
| Исходный код | Отношения | Целевой код |
| tub004-0007 (Rifampitsin (1,0 mg/ml)) | is narrower than | 18974-6 (Rifampin [Susceptibility]) |
| tub004-0008 (Izoniazid (0,1 mg/ml)) | is narrower than | 18934-0 (Isoniazid [Susceptibility]) |
| tub004-0009 (Etambutol (5,0 mg/ml)) | is narrower than | 18921-7 (Ethambutol [Susceptibility]) |
| tub004-0010 (Pirazinamid (100 mg/ml)) | is narrower than | 18973-8 (Pyrazinamide [Susceptibility]) |
| tub004-0011 (Levofloksatsin (2,0 mg/ml)) | is narrower than | 20629-2 (Levofloxacin [Susceptibility]) |
| tub004-0012 (Moksifloksatsin (1,0 mg/ml)) | is narrower than | 31039-1 (Moxifloxacin [Susceptibility]) |
| tub004-0013 (Moksifloksatsin (0,25 mg/ml)) | is narrower than | 31039-1 (Moxifloxacin [Susceptibility]) |
| tub004-0014 (Gatifloksatsin (0,25 mg/ml)) | is narrower than | 31038-3 (Gatifloxacin [Susceptibility]) |
| tub004-0015 (Amikatsin (1,0 mg/ml)) | is narrower than | 18860-7 (Amikacin [Susceptibility]) |
| tub004-0016 (Protionamid (2,5 mg/ml)) | is narrower than | 100057-9 (Prothionamide [Susceptibility]) |
| tub004-0017 (Linezolid (1,0 mg/ml)) | is narrower than | 29258-1 (Linezolid [Susceptibility]) |
| tub004-0018 (Klofazimin (1,0 mg/ml)) | is narrower than | 23627-3 (Clofazimine [Susceptibility]) |
| tub004-0019 (Bedaquilin (1,0 mg/ml)) | is narrower than | 94274-8 (Bedaquiline [Susceptibility]) |
| tub004-0020 (Delamanid (0,06 mg/ml)) | is narrower than | 93851-4 (Delamanid [Susceptibility]) |
| tub004-0021 (Pretomanid (1,0 mg/ml)) | is narrower than | 93850-6 (Pretomanid [Susceptibility]) |
| tub004-0025 (Ethionamide-Prothionamide) | is related to | 18922-5 (Ethionamide [Susceptibility]) |
| tub004-0022 (Rifampcin) | is equivalent to | 18974-6 (Rifampin [Susceptibility]) |
| tub004-0028 (Levofloxacin) | is equivalent to | 20629-2 (Levofloxacin [Susceptibility]) |
| tub004-0029 (Amikacin) | is equivalent to | 18860-7 (Amikacin [Susceptibility]) |
| tub004-0030 (Kanamycin) | is equivalent to | 18935-7 (Kanamycin [Susceptibility]) |
Uzbek
Generated Narrative: ConceptMap dhis-observation-component-to-loinc
Mapping from (not specified) to All LOINC codes
Mapping from DHIS Observation Component Code CodeSystemversion: 0.1.0) to http://loinc.org (Logical Observation Identifier Names and Codes (LOINC))
| Source Code | Relationship | Target Code |
| tub004-0007 (Rifampitsin (1,0 mg/ml)) | is narrower than | 18974-6 (Rifampin [Susceptibility]) |
| tub004-0008 (Izoniazid (0,1 mg/ml)) | is narrower than | 18934-0 (Isoniazid [Susceptibility]) |
| tub004-0009 (Etambutol (5,0 mg/ml)) | is narrower than | 18921-7 (Ethambutol [Susceptibility]) |
| tub004-0010 (Pirazinamid (100 mg/ml)) | is narrower than | 18973-8 (Pyrazinamide [Susceptibility]) |
| tub004-0011 (Levofloksatsin (2,0 mg/ml)) | is narrower than | 20629-2 (Levofloxacin [Susceptibility]) |
| tub004-0012 (Moksifloksatsin (1,0 mg/ml)) | is narrower than | 31039-1 (Moxifloxacin [Susceptibility]) |
| tub004-0013 (Moksifloksatsin (0,25 mg/ml)) | is narrower than | 31039-1 (Moxifloxacin [Susceptibility]) |
| tub004-0014 (Gatifloksatsin (0,25 mg/ml)) | is narrower than | 31038-3 (Gatifloxacin [Susceptibility]) |
| tub004-0015 (Amikatsin (1,0 mg/ml)) | is narrower than | 18860-7 (Amikacin [Susceptibility]) |
| tub004-0016 (Protionamid (2,5 mg/ml)) | is narrower than | 100057-9 (Prothionamide [Susceptibility]) |
| tub004-0017 (Linezolid (1,0 mg/ml)) | is narrower than | 29258-1 (Linezolid [Susceptibility]) |
| tub004-0018 (Klofazimin (1,0 mg/ml)) | is narrower than | 23627-3 (Clofazimine [Susceptibility]) |
| tub004-0019 (Bedaquilin (1,0 mg/ml)) | is narrower than | 94274-8 (Bedaquiline [Susceptibility]) |
| tub004-0020 (Delamanid (0,06 mg/ml)) | is narrower than | 93851-4 (Delamanid [Susceptibility]) |
| tub004-0021 (Pretomanid (1,0 mg/ml)) | is narrower than | 93850-6 (Pretomanid [Susceptibility]) |
| tub004-0025 (Ethionamide-Prothionamide) | is related to | 18922-5 (Ethionamide [Susceptibility]) |
| tub004-0022 (Rifampcin) | is equivalent to | 18974-6 (Rifampin [Susceptibility]) |
| tub004-0028 (Levofloxacin) | is equivalent to | 20629-2 (Levofloxacin [Susceptibility]) |
| tub004-0029 (Amikacin) | is equivalent to | 18860-7 (Amikacin [Susceptibility]) |
| tub004-0030 (Kanamycin) | is equivalent to | 18935-7 (Kanamycin [Susceptibility]) |
{
"resourceType": "ConceptMap",
"id": "dhis-observation-component-to-loinc",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"url": "https://terminology.dhp.uz/fhir/integrations/ConceptMap/dhis-observation-component-to-loinc",
"version": "0.1.0",
"name": "ObservationComponentToLoinc",
"title": "Tuberculosis Drug Susceptibility Components to LOINC",
"status": "draft",
"experimental": false,
"date": "2026-07-20T13:54:46+00:00",
"publisher": "Uzinfocom LLC",
"contact": [
{
"name": "Uzinfocom LLC",
"telecom": [
{
"system": "url",
"value": "https://uzinfocom.uz"
},
{
"system": "email",
"value": "info@uzinfocom.uz"
}
]
}
],
"description": "Maps the local DHIS drug-susceptibility-test component codes to their LOINC [Susceptibility] code. Where the relationship is `equivalent` (plain drug-name agents), use the LOINC code directly in resources (see the DHIS Observation Component Code ValueSet); concentration-bearing agents are narrower and keep their local code. Non-drug component codes (interpretations, grading, identification flags) have no LOINC equivalent and are not listed.",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "UZ",
"display": "Uzbekistan"
}
]
}
],
"targetScopeCanonical": "http://loinc.org/vs",
"group": [
{
"source": "https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs|0.1.0",
"target": "http://loinc.org",
"element": [
{
"code": "tub004-0007",
"display": "Rifampitsin (1,0 mg/ml)",
"target": [
{
"code": "18974-6",
"display": "Rifampin [Susceptibility]",
"relationship": "source-is-narrower-than-target"
}
]
},
{
"code": "tub004-0008",
"display": "Izoniazid (0,1 mg/ml)",
"target": [
{
"code": "18934-0",
"display": "Isoniazid [Susceptibility]",
"relationship": "source-is-narrower-than-target"
}
]
},
{
"code": "tub004-0009",
"display": "Etambutol (5,0 mg/ml)",
"target": [
{
"code": "18921-7",
"display": "Ethambutol [Susceptibility]",
"relationship": "source-is-narrower-than-target"
}
]
},
{
"code": "tub004-0010",
"display": "Pirazinamid (100 mg/ml)",
"target": [
{
"code": "18973-8",
"display": "Pyrazinamide [Susceptibility]",
"relationship": "source-is-narrower-than-target"
}
]
},
{
"code": "tub004-0011",
"display": "Levofloksatsin (2,0 mg/ml)",
"target": [
{
"code": "20629-2",
"display": "Levofloxacin [Susceptibility]",
"relationship": "source-is-narrower-than-target"
}
]
},
{
"code": "tub004-0012",
"display": "Moksifloksatsin (1,0 mg/ml)",
"target": [
{
"code": "31039-1",
"display": "Moxifloxacin [Susceptibility]",
"relationship": "source-is-narrower-than-target"
}
]
},
{
"code": "tub004-0013",
"display": "Moksifloksatsin (0,25 mg/ml)",
"target": [
{
"code": "31039-1",
"display": "Moxifloxacin [Susceptibility]",
"relationship": "source-is-narrower-than-target"
}
]
},
{
"code": "tub004-0014",
"display": "Gatifloksatsin (0,25 mg/ml)",
"target": [
{
"code": "31038-3",
"display": "Gatifloxacin [Susceptibility]",
"relationship": "source-is-narrower-than-target"
}
]
},
{
"code": "tub004-0015",
"display": "Amikatsin (1,0 mg/ml)",
"target": [
{
"code": "18860-7",
"display": "Amikacin [Susceptibility]",
"relationship": "source-is-narrower-than-target"
}
]
},
{
"code": "tub004-0016",
"display": "Protionamid (2,5 mg/ml)",
"target": [
{
"code": "100057-9",
"display": "Prothionamide [Susceptibility]",
"relationship": "source-is-narrower-than-target"
}
]
},
{
"code": "tub004-0017",
"display": "Linezolid (1,0 mg/ml)",
"target": [
{
"code": "29258-1",
"display": "Linezolid [Susceptibility]",
"relationship": "source-is-narrower-than-target"
}
]
},
{
"code": "tub004-0018",
"display": "Klofazimin (1,0 mg/ml)",
"target": [
{
"code": "23627-3",
"display": "Clofazimine [Susceptibility]",
"relationship": "source-is-narrower-than-target"
}
]
},
{
"code": "tub004-0019",
"display": "Bedaquilin (1,0 mg/ml)",
"target": [
{
"code": "94274-8",
"display": "Bedaquiline [Susceptibility]",
"relationship": "source-is-narrower-than-target"
}
]
},
{
"code": "tub004-0020",
"display": "Delamanid (0,06 mg/ml)",
"target": [
{
"code": "93851-4",
"display": "Delamanid [Susceptibility]",
"relationship": "source-is-narrower-than-target"
}
]
},
{
"code": "tub004-0021",
"display": "Pretomanid (1,0 mg/ml)",
"target": [
{
"code": "93850-6",
"display": "Pretomanid [Susceptibility]",
"relationship": "source-is-narrower-than-target"
}
]
},
{
"code": "tub004-0025",
"display": "Ethionamide-Prothionamide",
"target": [
{
"code": "18922-5",
"display": "Ethionamide [Susceptibility]",
"relationship": "related-to"
}
]
},
{
"code": "tub004-0022",
"display": "Rifampcin",
"target": [
{
"code": "18974-6",
"display": "Rifampin [Susceptibility]",
"relationship": "equivalent"
}
]
},
{
"code": "tub004-0028",
"display": "Levofloxacin",
"target": [
{
"code": "20629-2",
"display": "Levofloxacin [Susceptibility]",
"relationship": "equivalent"
}
]
},
{
"code": "tub004-0029",
"display": "Amikacin",
"target": [
{
"code": "18860-7",
"display": "Amikacin [Susceptibility]",
"relationship": "equivalent"
}
]
},
{
"code": "tub004-0030",
"display": "Kanamycin",
"target": [
{
"code": "18935-7",
"display": "Kanamycin [Susceptibility]",
"relationship": "equivalent"
}
]
}
]
}
]
}